PUTNAM HEALTH SCIENCES TRUST
NSAR-B, EX-27, 2000-10-27
Previous: PUTNAM HEALTH SCIENCES TRUST, NSAR-B, EX-27, 2000-10-27
Next: PUTNAM HEALTH SCIENCES TRUST, NSAR-B, EX-99, 2000-10-27


WARNING: THE EDGAR SYSTEM ENCOUNTERED ERROR(S) WHILE PROCESSING THIS SCHEDULE.

<TABLE> <S> <C>

<ARTICLE> 6
<LEGEND>
Putnam Health Sciences Trust
</LEGEND>
<SERIES>
   <NUMBER> 5
   <NAME> CLASS Y

<S>                             <C>
<PERIOD-TYPE>                   ANNUAL
<FISCAL-YEAR-END>                          AUG-31-2000
<PERIOD-END>                               AUG-31-2000
<INVESTMENTS-AT-COST>                    4,321,877,088
<INVESTMENTS-AT-VALUE>                   7,032,745,711
<RECEIVABLES>                              125,041,571
<ASSETS-OTHER>                              12,525,546
<OTHER-ITEMS-ASSETS>                                 0
<TOTAL-ASSETS>                           7,170,312,828
<PAYABLE-FOR-SECURITIES>                    92,787,375
<SENIOR-LONG-TERM-DEBT>                              0
<OTHER-ITEMS-LIABILITIES>                   21,246,627
<TOTAL-LIABILITIES>                        114,034,002
<SENIOR-EQUITY>                                      0
<PAID-IN-CAPITAL-COMMON>                 4,027,907,225
<SHARES-COMMON-STOCK>                          386,112
<SHARES-COMMON-PRIOR>                                0
<ACCUMULATED-NII-CURRENT>                            0
<OVERDISTRIBUTION-NII>                               0
<ACCUMULATED-NET-GAINS>                    317,555,789
<OVERDISTRIBUTION-GAINS>                             0
<ACCUM-APPREC-OR-DEPREC>                 2,710,815,812
<NET-ASSETS>                             7,056,278,826
<DIVIDEND-INCOME>                           36,457,121
<INTEREST-INCOME>                            9,236,936
<OTHER-INCOME>                                       0
<EXPENSES-NET>                              70,894,535
<NET-INVESTMENT-INCOME>                   (25,200,478)
<REALIZED-GAINS-CURRENT>                   382,861,779
<APPREC-INCREASE-CURRENT>                1,500,933,605
<NET-CHANGE-FROM-OPS>                    1,858,594,906
<EQUALIZATION>                                       0
<DISTRIBUTIONS-OF-INCOME>                            0
<DISTRIBUTIONS-OF-GAINS>                             0
<DISTRIBUTIONS-OTHER>                                0
<NUMBER-OF-SHARES-SOLD>                        431,899
<NUMBER-OF-SHARES-REDEEMED>                   (45,787)
<SHARES-REINVESTED>                                  0
<NET-CHANGE-IN-ASSETS>                   1,933,920,330
<ACCUMULATED-NII-PRIOR>                              0
<ACCUMULATED-GAINS-PRIOR>                            0
<OVERDISTRIB-NII-PRIOR>                              0
<OVERDIST-NET-GAINS-PRIOR>                  58,779,830
<GROSS-ADVISORY-FEES>                       30,278,723
<INTEREST-EXPENSE>                                   0
<GROSS-EXPENSE>                             71,755,066
<AVERAGE-NET-ASSETS>                        25,273,766
<PER-SHARE-NAV-BEGIN>                            70.52
<PER-SHARE-NII>                                    .03
<PER-SHARE-GAIN-APPREC>                          11.73
<PER-SHARE-DIVIDEND>                                 0
<PER-SHARE-DISTRIBUTIONS>                            0
<RETURNS-OF-CAPITAL>                                 0
<PER-SHARE-NAV-END>                              82.28
<EXPENSE-RATIO>                                    .28
[AVG-DEBT-OUTSTANDING]                               0
[AVG-DEBT-PER-SHARE]                                 0


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission